SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Goldman Sachs Raises Pfizer Price Target to $28 From $26

Goldman Sachs adjusted its Pfizer price target to $28 from $26 as part of its updated valuation analysis.

PFE

Related stories